SPOTLIGHT -
Recent studies and reviews report great progress in bringing TD under control.
The 2024 APA Annual Meeting: Tuesday, May 7
Treating ‘Morally Objectionable’ Patients
Investigators Share Baseline Data From Study on Iclepertin for Schizophrenia at APA Annual Meeting
More Than Postpartum Depression: Addressing Maternal Mental Health Through the Life Cycle
Neurocrine Biosciences Announces Collaboration With Participants of Tardive Dyskinesia Awareness Week
Tardive Dyskinesia in US Antipsychotic Users